These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3904417)

  • 21. Bone marrow purging for multiple myeloma by avidin-biotin immunoadsorption.
    Lemoli RM; Gobbi M; Tazzari PL; Tassi TC; Dinota A; Visani G; Grassi G; Mazza P; Cavo M; Tura S
    Transplantation; 1989 Feb; 47(2):385-7. PubMed ID: 2645722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research Progress on Multiple Myeloma with Extramedullary Disease].
    Wang L; Zhang YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):945-8. PubMed ID: 27342539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The immunological phenotype and proliferative activity of the tumor lymphocytes in multiple myeloma].
    Golenkov AK; Nazarova IN; Sarycheva TG; Miterev GIu; Kozinets GI
    Ter Arkh; 1993; 65(7):38-41. PubMed ID: 8211777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Plasmocytic pleural effusion disclosing multiple myeloma].
    Elloumi M; Frikha M; Masmoudi H; Mseddi S; Ben Ayed M; Bouaziz M; Makni F; Souissi T
    Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple myeloma: expression of nucleoside transporters on malignant plasma cells and their relationship to cellular proliferation.
    Petersen AJ; Brown RD; Pope BB; Jamieson GP; Paterson AR; Gibson J; Wiley JS; Joshua DE
    Leuk Lymphoma; 1994 May; 13(5-6):491-9. PubMed ID: 8069194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma cell morphology in multiple myeloma and related disorders.
    Ribourtout B; Zandecki M
    Morphologie; 2015 Jun; 99(325):38-62. PubMed ID: 25899140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow aspirate immunofluorescent and bone marrow biopsy immunoperoxidase staining of plasma cells in histologically occult plasma cell proliferative marrow disorders.
    Menke DM; Greipp PR; Colon-Otero G; Solberg LA; Cockerill KJ; Hook CC; Witzig TE
    Arch Pathol Lab Med; 1994 Aug; 118(8):811-4. PubMed ID: 7520228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phagocytic, lambda light chain, plasma cell myeloma.
    Wirt DP; Grogan TM; Payne CM; Kummet TD; Durie BG; Finley PR; Rollins D
    Am J Clin Pathol; 1983 Jul; 80(1):75-84. PubMed ID: 6190396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38/propidium iodide double staining technique.
    Orfäo A; García-Sanz R; López-Berges MC; Belén Vidriales M; González M; Caballero MD; San Miguel JF
    Cytometry; 1994 Dec; 17(4):332-9. PubMed ID: 7533074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine.
    Sasaki K; Murakami T; Ogino T; Takahashi M; Kawasaki S
    Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human myeloma in vitro colony growth: interrelationships between drug sensitivity, cell kinetics, and patient survival duration.
    Durie BG; Young LA; Salmon SE
    Blood; 1983 May; 61(5):929-34. PubMed ID: 6831055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of human myeloma cell population kinetics.
    Montecucco C; Riccardi A; Ucci G; Danova M; Carnevale R; Caporali R; Longhi M; Luoni R
    Acta Haematol; 1986; 75(3):153-6. PubMed ID: 3092531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant plasmacytic ascites. A report of two cases and a review of the literature.
    Greer JP; Pinson RD; Russell WG; Keith TA; Collins RD; Graber SE
    Cancer; 1985 Oct; 56(8):2001-4. PubMed ID: 2411386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
    Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
    Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma cell acid phosphatase activity as prognostic factor in multiple myeloma: relationship to the thymidine-labeling index.
    Boccadoro M; Gallamini A; Fruttero A; Gavarotti P; Redoglia V; Buffa F; Ruá S; Pileri A
    J Clin Oncol; 1985 Nov; 3(11):1503-7. PubMed ID: 4056842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility and sensitivity of anti BrdU antibodies in assessing S-phase cells compared to autoradiography.
    Raza A; Ucar K; Bhayana R; Kempski M; Preisler HD
    Cell Biochem Funct; 1985 Apr; 3(2):149-53. PubMed ID: 3915232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ploidy and proliferative characteristics in monoclonal gammopathies.
    Latreille J; Barlogie B; Johnston D; Drewinko B; Alexanian R
    Blood; 1982 Jan; 59(1):43-51. PubMed ID: 6172171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibody Ki-67 as a marker of proliferative activity in monoclonal gammopathies.
    Girino M; Riccardi A; Luoni R; Ucci G; Cuomo A
    Acta Haematol; 1991; 85(1):26-30. PubMed ID: 2011926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell proliferation of myeloma plasma cells: comparison of the blood and marrow compartments.
    Kumar S; Rajkumar SV; Greipp PR; Witzig TE
    Am J Hematol; 2004 Sep; 77(1):7-11. PubMed ID: 15307099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial bone marrow findings in multiple myeloma. Significance of plasma cell nodules.
    Buss DH; Prichard RW; Hartz JW; Cooper MR; Feigin GA
    Arch Pathol Lab Med; 1986 Jan; 110(1):30-3. PubMed ID: 3753566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.